## Abstract Breast cancer, especially estrogen receptor (ER)βnegative breast cancer, remains hard to treat despite major advances in surgery and adjuvant therapies. The deletion of ER has been consistently associated with tumor progression, recurrence, metastasis and poor prognosis. Among other dif
Physical activity as a negative modulator of estrogen-induced breast cancer
β Scribed by Yvonne M. Coyle
- Publisher
- Springer Netherlands
- Year
- 2008
- Tongue
- English
- Weight
- 252 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The interaction between 17Ξ²βestradiol and estrogen receptor alpha (ERβΞ±) plays an important role in breast carcinogenesis and breast cancer treatment. ERβΞ± is a critical growth regulatory gene in breast cancer and its expression level is tightly linked to the prognosis and treatment out
## Abstract Adipositas correlates with an enhanced risk of developing malignant diseases such as breast cancer, endometrial tumor or prostate carcinoma, but the molecular basis for this is not well understood. Potential mechanisms include increased bioavailability of adipocytokines (__e.g.__ leptin
To assess the value of estrogen receptor protein (ERP) as a predictor of tumor recurrence, 556 patients treated by mastectomy between 1973 and 1978 for primary operable breast cancer had ERP determination of their tumors. All patients had histologically negative nodes. Two hundred fifty-six patients